A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial | Zendy

Bente Langdahl | Zendy; Christence Stubbe Teglbjærg | Zendy; PeiRan Ho | Zendy; Roland Chapurlat | Zendy; E. J. Czerwiński | Zendy; David L. Kendler | Zendy; JeanYves Reginster | Zendy; Alan Kivitz | Zendy; E. Michael Lewiecki | Zendy; Paul D. Miller | Zendy; Michael A. Bolognese | Zendy; Michael R. McClung | Zendy; Henry G. Bone | Zendy; Östen Ljunggren | Zendy; Bo Abrahamsen | Zendy; Uģis Gruntmanis | Zendy; Yuching Yang | Zendy; Rachel B. Wagman | Zendy; Faisal M. Mirza | Zendy; Suresh Siddhanti | Zendy; Eric Orwoll | Zendy

Open Access

A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial

Author(s) -

Bente Langdahl,

Christence Stubbe Teglbjærg,

PeiRan Ho,

Roland Chapurlat,

E. J. Czerwiński,

David L. Kendler,

JeanYves Reginster,

Alan Kivitz,

E. Michael Lewiecki,

Paul D. Miller,

Michael A. Bolognese,

Michael R. McClung,

Henry G. Bone,

Östen Ljunggren,

Bo Abrahamsen,

Uģis Gruntmanis,

Yuching Yang,

Rachel B. Wagman,

Faisal M. Mirza,

Suresh Siddhanti,

Eric Orwoll

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-4079

Subject(s) - denosumab , medicine , bone mineral , femoral neck , osteoporosis , placebo , adverse effect , urology , n terminal telopeptide , bone density , phases of clinical research , surgery , clinical trial , osteocalcin , pathology , biochemistry , chemistry , alkaline phosphatase , alternative medicine , enzyme

One in 4 men in the United States aged >50 years will have an osteoporosis-related fracture. Fewer data are available on osteoporosis treatment in men than in women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research